Skip to main content
. 2016 Mar 17;14(3):488–492. doi: 10.5114/aoms.2016.58650

Table III.

Comparison of dobutamine echocardiography parameters in the two groups

Parameter 3DCLDDEMean, standard deviation(95% CI) LDDEMean, standard deviation(95% CI) P-value
WMSI at rest 1.36 ±0.14 (1.31–1.41) 1.41 ±0.23 (1.33–1.48) 0.34
WMSI at peak dose 1.21 ±0.18 (1.27–1.15) 1.27 ±0.2 (1.2–1.34) 0.32
WMSI increase 0.15 ±0.09 (0.12–0.18) 0.17 ±0.24 (0.09–0.25) 0.58
Maximum dobutamine dose 19.7 ±4.6 (18–21) 22.7 ±7.0 (20–25) 0.052
Duration of dobutamine test 11.3 ±2.5 (10–12) 12.1 ±3.3 (11–13) 0.35
Resting heart rate 68 ±10 (65–72) 64 ±10 (60–61) 0.06
Resting blood pressure 116 ±15 (111–121)/67 ±9 (64–70) 126 ±12 (121–130)/71 ±10 (68–74) 0.009/0.11
Heart rate at peak dose 82 ±18 (75–87) 87 ±23 (79–94) 0.31
Blood pressure at peak dose 131 ±23 (123–138)/70 ±12 (66–70) 149 ±24 (141–157)/71 ±12 (67–75) 0.005/0.73
Contrast agent dose per patient [ml] 5.4